Director, Takeda Pharmaceutical Company Limited
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) and dividends retained by asset-management companies (less about 20% corporate tax), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited 4502 · FY ending Mar 2026 · Director |
Own name | 19,756 | — | ¥5,663 | ¥112M | ¥4.0M |